Drug Mix-Up Blinds Patient, Spurs Malpractice Verdict
Cataract patient given methylene blue instead of VisionBlue.
Published: August 22, 2014
A mix-up over sound-alike drugs is at the heart of a $1.5 million jury award earlier this week stemming from a botched cataract procedure that left a patient blind in one eye.
You might say the cataract team at North Carolina Specialty Hospital blue it. Ophthalmologist Timothy Young, MD, PhD, who at the time was practicing with co-defendant North Carolina Eye, Ear, Nose and Throat, in Durham, called for the ophthalmic dye VisionBlue during a cataract removal in 2008, according to news reports. But a nurse instead retrieved methylene blue, a compound sometimes used in endoscopic polypectomies and one that's toxic to eyes.
Both the nurse and a surgical technician testified that they announced what the drug was before it was given to Dr. Young, but he testified that he didn't hear them.
A second procedure to repair the severe damage caused by the mix-up failed, as did a full corneal transplant.
Calls for comment by Outpatient Surgery Magazine to Dr. Young, who now practices in Texas, and to North Carolina Eye, Ear, Nose and Throat, were not returned.
© Copyright Herrin Publishing Partners LP. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.
Also in the News...
CMS Announces Outpatient Rates for 2016
Patient Says She Was Bullied into Signing Consent Form
Connecticut Provider Tax Could Force Centers to Close Across State
Insufficient Evidence to Link Nail Polish, Rings to SSIs
Colonoscopy Patient's Cell Phone Records Doctor's Insults
Florida Skin-Cancer Doc Agrees to Pay Feds $4 Million
Can Antibiotics Successfully Treat Appendicitis?